Sodium alginate |
ATDC5 chondrogenic cell line |
Inkjet bioprinting |
Compressive modulus: 20–70 kPa |
~85% cell viability Cartilage ECM deposition |
[113] |
Alginate with cellulose nanofibers |
Human nasoseptal chondrocytes |
Inkjet bioprinting |
Compressive modulus: 75–250 kPa |
73–86% cell viability |
[115] |
Alginate with cellulose nanofibers |
Human nasoseptal chondrocytes |
Extrusion bioprinting |
Compressive stress: 15–88 kPa |
Cartilage ECM deposition |
[116] |
Alginate with cellulose nanofibers |
Human nasoseptal chondrocytes and MSCs |
Extrusion bioprinting |
Not reported |
Chondrogenic differentiation Chondrocytes proliferation |
[117] |
Alginate with gellan |
Bovine articular chondrocytes |
Extrusion bioprinting |
Tensile modulus: 116–230 kPa |
80–96% cell viability. Cartilage ECM deposition Chondrocytes proliferation |
[118] |
Methacrylated HA with diacrylated Pluronic |
Bovine articular chondrocytes |
Inkjet bioprinting |
Compressive modulus: 1.5–6.5 kPa |
62–86% cell viability |
[120] |
HA with dextran derived |
Equine articular chondrocytes |
Extrusion bioprinting |
Ultimate compressive stress: 100–160 kPa |
>75% cell viability |
[121] |
GelMA with HA |
Equine articular chondrocytes |
Inkjet bioprinting |
Compressive modulus: 5–180 kPa |
>73% cell viability |
[127] |
GelMA with HA-methacrylate |
Human bone marrow MSCs |
Extrusion bioprinting |
Compressive modulus: 48–100 kPa |
85–95% cell viability.Chondrogenic differentiation |
[126] |
GelMA |
Equine ACPCs/Chondrocytes/MSCs |
Inkjet bioprinting |
Compressive modulus: 100–187 kPa |
>75% cell viability |
[125] |
PEGDMA |
Human articular chondrocytes |
Inkjet bioprinting |
Compressive modulus: ~400 kPa |
89% cell viability Cartilage ECM deposition |
[128] |
PEG-GelMA |
Human MSCs |
Inkjet bioprinting |
Compressive modulus: ~1 MPa |
~80% cell viability Cartilage ECM deposition Chondrogenic differentiation |
[129] |
Alginate reinforced with PCL |
Embryonic chick chondrocytes |
Extrusion bioprinting |
Not reported |
77–85% cell viability Cartilage ECM deposition |
[132] |
Alginate reinforced with PCL + TGFβ |
Human nososeptal chondrocytes |
Extrusion bioprinting |
Not reported |
85% cell viability Cartilage ECM deposition |
[131] |
Alginate reinforced with PCL |
C20A4 human chondrocyte cell line |
Extrusion bioprinting |
Compressive modulus: 6 MPa |
~70% cell viability |
[130] |